The Exploratory Study on the Nicotinamide Mononucleotide (Vital NAD ) to Promote the Rejuvenation of the Peripheral Blood Immune Cells of Adults.
Clinical trial NCT05984550 · UNKNOWN
Trial details
- NCT number
- NCT05984550
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-01
- Primary completion
- 2024-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.